饮食疗法对肺癌化疗患者恶心呕吐的临床影响研究  

Clinical Effect of Diet Therapy on Nausea and Vomiting in Patients with Lung Cancer Chemotherapy

作　　者：蒋晶红[1] JIANG Jing-hong(Nutriology Department, Jilin Central Hospital, Jilin, Jilin 132000)

机构地区：[1]吉林市中心医院营养科

出　　处：《智慧健康》2019年第20期165-166,共2页Smart Healthcare

摘　　要：目的研究分析对肺癌化疗患者行饮食疗法后,对恶心呕吐的临床影响情况。方法选择2017年1月至2018年12月到我院接受化疗治疗的300例肺癌患者,随机划分为A组(150例)与B组(150例),均接受相同的化疗方案治疗,A组接受常规护理干预,B组在其基础上行饮食疗法干预,观察统计不同时间恶心呕吐发生几率以及生活质量情况,并对比评价。结果化疗后24 h内以及化疗24 h后对比恶心呕吐发生几率比较,结果显示B组明显低于A组(P<0.05);组间对比生活质量评分,结果显示B组较A组高(P<0.05)。结论对于接受化疗治疗的肺癌患者,在常规治疗以及护理的基础上,予以饮食疗法能够有效改善其恶心呕吐现象,从而提升生活质量,在临床中具有可观的推广价值。Objective To study and analyze the clinical effect of diet therapy on nausea and vomiting in patients with lung cancer undergoing chemotherapy. Methods A total of 300 patients with lung cancer who underwent chemotherapy in our hospital from January 2017 to December 2018 were randomly assigned to group A (150 patients) and group B (150 patients), all receiving the same chemotherapy regimen. Group A received routine nursing intervention, group B underwent basic dietary therapy intervention, and the incidence of nausea and vomiting and quality of life at different times were observed and compared. Results Comparing the incidence of nausea and vomiting within 24 hours after chemotherapy and 24 hours after chemotherapy, the results showed that the incidence of nausea and vomiting in group B was significantly lower than that in group A (P<0.05). The comparison of quality of life scores between groups showed that group B was higher than group A (P<0.05). Conclusion For patients with lung cancer undergoing chemotherapy, dietary therapy can effectively improve nausea and vomiting on the basis of routine treatment and nursing, thereby improving the quality of life and having considerable promotion value in clinical practice.

关 键 词：恶心呕吐 饮食疗法 肺癌 化疗 

分 类 号：R473.73[医药卫生—护理学]